This inventor holds 1 USPTO granted patent. Top assignee: Siegfried Ltd.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovations of Andreas Bertogg
Introduction
Andreas Bertogg is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of chemistry, particularly in the area of alkaloid derivatives. His work has led to advancements that are valuable in various applications.
Latest Patents
Andreas Bertogg holds a patent for the "Demethylation of 14-hydroxy substituted alkaloid derivatives." This invention focuses on a method for demethylating 14-hydroxy substituted alkaloid derivatives, specifically targeting 14-hydroxy-17-methyl-4,5-epoxymorphinane-6-on-derivatives. The process involves reacting a starting compound with a compound of general formula ROOC—N≡N—COOR in a suitable solvent. This innovative method showcases his expertise in chemical processes.
Career Highlights
Bertogg is associated with Siegfried Ltd., a company known for its commitment to pharmaceutical development and manufacturing. His role at the company has allowed him to apply his knowledge and skills in a practical setting, contributing to the advancement of pharmaceutical sciences.
Collaborations
Throughout his career, Andreas has collaborated with esteemed colleagues such as Erik Heinz Lauterbach and Thomas Dinkel. These partnerships have fostered a collaborative environment that enhances innovation and research.
Conclusion
Andreas Bertogg's contributions to the field of chemistry, particularly through his patent on alkaloid derivatives, highlight his role as an influential inventor. His work continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile